Cargando…

Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure

The absence of a gold standard to determine when antibiotics have induced sterilizing cure confounds the development of new approaches to treat pulmonary tuberculosis (PTB). We detected PET-CT imaging response patterns consistent with active disease along with the presence of Mycobacterium tuberculo...

Descripción completa

Detalles Bibliográficos
Autores principales: Malherbe, Stephanus T., Shenai, Shubhada, Ronacher, Katharina, Loxton, Andre G., Dolganov, Gregory, Kriel, Magdalena, Van, Tran, Chen, Ray Y., Warwick, James, Via, Laura E., Song, Taeksun, Lee, Myungsun, Schoolnik, Gary, Tromp, Gerard, Alland, David, Barry, Clifton E., Winter, Jill, Walzl, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053881/
https://www.ncbi.nlm.nih.gov/pubmed/27595324
http://dx.doi.org/10.1038/nm.4177
_version_ 1782458485109161984
author Malherbe, Stephanus T.
Shenai, Shubhada
Ronacher, Katharina
Loxton, Andre G.
Dolganov, Gregory
Kriel, Magdalena
Van, Tran
Chen, Ray Y.
Warwick, James
Via, Laura E.
Song, Taeksun
Lee, Myungsun
Schoolnik, Gary
Tromp, Gerard
Alland, David
Barry, Clifton E.
Winter, Jill
Walzl, Gerhard
author_facet Malherbe, Stephanus T.
Shenai, Shubhada
Ronacher, Katharina
Loxton, Andre G.
Dolganov, Gregory
Kriel, Magdalena
Van, Tran
Chen, Ray Y.
Warwick, James
Via, Laura E.
Song, Taeksun
Lee, Myungsun
Schoolnik, Gary
Tromp, Gerard
Alland, David
Barry, Clifton E.
Winter, Jill
Walzl, Gerhard
author_sort Malherbe, Stephanus T.
collection PubMed
description The absence of a gold standard to determine when antibiotics have induced sterilizing cure confounds the development of new approaches to treat pulmonary tuberculosis (PTB). We detected PET-CT imaging response patterns consistent with active disease along with the presence of Mycobacterium tuberculosis mRNA in sputum and bronchoalveolar lavage samples in a substantial proportion of adult, HIV-negative PTB patients after standard 6-month treatment plus one year follow-up, including patients with a durable cure and others who later developed recurrent disease. The presence of MTB mRNA in the context of non-resolving and intensifying lesions on PET-CT might indicate ongoing transcription, suggesting that even apparently curative PTB treatment may not eradicate all organisms in most patients. This suggests an important complementary role for the immune response in maintaining a disease-free state. Sterilizing drugs or host-directed therapies and better treatment response markers are likely needed for the successful development of improved and shortened PTB treatment strategies.
format Online
Article
Text
id pubmed-5053881
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-50538812017-03-05 Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure Malherbe, Stephanus T. Shenai, Shubhada Ronacher, Katharina Loxton, Andre G. Dolganov, Gregory Kriel, Magdalena Van, Tran Chen, Ray Y. Warwick, James Via, Laura E. Song, Taeksun Lee, Myungsun Schoolnik, Gary Tromp, Gerard Alland, David Barry, Clifton E. Winter, Jill Walzl, Gerhard Nat Med Article The absence of a gold standard to determine when antibiotics have induced sterilizing cure confounds the development of new approaches to treat pulmonary tuberculosis (PTB). We detected PET-CT imaging response patterns consistent with active disease along with the presence of Mycobacterium tuberculosis mRNA in sputum and bronchoalveolar lavage samples in a substantial proportion of adult, HIV-negative PTB patients after standard 6-month treatment plus one year follow-up, including patients with a durable cure and others who later developed recurrent disease. The presence of MTB mRNA in the context of non-resolving and intensifying lesions on PET-CT might indicate ongoing transcription, suggesting that even apparently curative PTB treatment may not eradicate all organisms in most patients. This suggests an important complementary role for the immune response in maintaining a disease-free state. Sterilizing drugs or host-directed therapies and better treatment response markers are likely needed for the successful development of improved and shortened PTB treatment strategies. 2016-09-05 2016-10 /pmc/articles/PMC5053881/ /pubmed/27595324 http://dx.doi.org/10.1038/nm.4177 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Malherbe, Stephanus T.
Shenai, Shubhada
Ronacher, Katharina
Loxton, Andre G.
Dolganov, Gregory
Kriel, Magdalena
Van, Tran
Chen, Ray Y.
Warwick, James
Via, Laura E.
Song, Taeksun
Lee, Myungsun
Schoolnik, Gary
Tromp, Gerard
Alland, David
Barry, Clifton E.
Winter, Jill
Walzl, Gerhard
Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
title Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
title_full Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
title_fullStr Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
title_full_unstemmed Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
title_short Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure
title_sort persisting pet-ct lesion activity and m. tuberculosis mrna after pulmonary tuberculosis cure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053881/
https://www.ncbi.nlm.nih.gov/pubmed/27595324
http://dx.doi.org/10.1038/nm.4177
work_keys_str_mv AT malherbestephanust persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT shenaishubhada persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT ronacherkatharina persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT loxtonandreg persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT dolganovgregory persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT krielmagdalena persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT vantran persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT chenrayy persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT warwickjames persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT vialaurae persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT songtaeksun persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT leemyungsun persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT schoolnikgary persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT trompgerard persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT allanddavid persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT barrycliftone persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT winterjill persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT walzlgerhard persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure
AT persistingpetctlesionactivityandmtuberculosismrnaafterpulmonarytuberculosiscure